NELLY enables patient-centric drug prioritization through interpretable drug-conditioned gene weighting
Peralta Viteri, C.; Harnischfeger, N.; Szabo, L.; Hartmann, S.; Kretzschmar, K.
Show abstract
Precision oncology seeks to match each tumor with the most effective anti-cancer therapy. Advances in pharmacogenomics and machine learning enabled drug response prediction models with strong performance in cancer cell lines. Nonetheless, patient-centric evaluation of drug prioritization and systematic assessment of model generalization in patient-derived systems across cancer types remain largely absent. Here we introduce a translational framework combining patient-centric benchmarking with a pan-cancer pharmacogenomic atlas of patient-derived organoids, together with NELLY, a deep learning model integrating transcriptomic and chemical information to predict drug response and prioritize therapies. NELLY outperformed existing methods for patient-specific drug prioritization across cancer cell lines and patient-derived organoids, including under out-of-distribution evaluation. Its dynamic weighting mechanism provided patient-specific gene attributions, offering a route to connect predicted drug response to molecular programs associated with drug resistance. Our results support NELLY as a promising framework for translationally relevant and interpretable drug response prediction in precision oncology.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Knowledge Connector: Decision support system for multiomics-based precision oncology 96%
- Features fusion or not: harnessing multiple pathological foundation models using Meta-Encoder for downstream tasks fine-tuning 95%
- Community assessment of cancer drug combination screens identifies strategies for synergy prediction 95%
Similar papers in this journal
- Path2Omics: Enhanced transcriptomic and methylation prediction accuracy from tumor histopathology 96%
- Comprehensive Benchmarking and Integration of Tumour Microenvironment Cell Estimation Methods 92%
- Biomarker-guided treatment strategies for ovarian cancer identified from a heterogeneous panel of patient-derived tumor xenografts 92%
Similar papers in this journal
- Deep learning inference of cell type-specific gene expression from breast tumor histopathology 96%
- Predicting the Tumor Microenvironment Composition and Immunotherapy Response in Non-Small Cell Lung Cancer from Digital Histopathology Images 94%
- Real-World Benchmarking and Validation of Foundation Model Transformers for Endometrial Cancer Subtyping from Histopathology 94%
Similar papers in this journal
- Clinical interpretation of integrative molecular profiles to guide precision cancer medicine 95%
- Decoding pan-cancer treatment outcomes using multimodal real-world data and explainable artificial intelligence 94%
- Multiplexed mosaic tumor models reveal natural phenotypic variations in drug response within and between populations 94%
Similar papers in this journal
- High-Sensitivity Pan-Cancer AI Assessment of Lymph Node Metastasis via Uncertainty Quantification 95%
- DeePaN: A deep patient graph convolutional network integrating clinico-genomic evidence to stratify lung cancers benefiting from immunotherapy 95%
- Cross-Platform Omics Prediction procedure enables precision medicine in patients with stage-III melanoma 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.